Type 2 & other diabetes

Low‐grade inflammation in persons with recently diagnosed type 2 diabetes: The role of abdominal adiposity and putative mediators

Diabetes Obes MetabPublished Cross-sectional study

Authors' conclusion

In persons with recently diagnosed T2D, there was a clear association between abdominal adiposity and low-grade inflammation. A considerable part (20%-40%) of this association was mediated by other factors, with hyperinsulinaemia as a potentially important driver of adiposity-induced inflammation in T2D.

Study context

Population
Persons with recently diagnosed T2D
Participants
>9,000 persons
Outcome
Association between abdominal adiposity (waist circumference) and low-grade inflammation (TNF-α, IL-6, hsCRP), and its mediation by physical activity, hyperinsulinaemia, hyperglycaemia, dyslipidaemia, hypertension and comorbidities
Methodological detailsmultiple mediation analysis using structural equation modelling, adjusted for age and sex
  • Multiple mediation analysis using structural equation modelling
  • Adjusted for age and sex

Main finding

As reported in the abstract

Inflammatory markers per 1-SD increase in waist circumference (SD = 15 cm)

SD increase in TNF-α (SD = 1.5 pg/mL)

22%

SD increase in IL-6 (SD = 4.4 pg/mL)

35%

SD increase in high-sensitivity C-reactive protein (hsCRP) (SD = 6.9 mg/L)

46%

Observational data: associations, not effects.

Further findings

Mediators of the adiposity–inflammation association (proportion mediated)

Hyperinsulinaemia (fasting C-peptide), most important mediator
9%-25%
Low physical activity
5%-7%
High TG levels
2%-6%
Greater comorbidity and higher HbA1c (statistically significant, minor impact)
1%-2%

Original publication

Low‐grade inflammation in persons with recently diagnosed type 2 diabetes: The role of abdominal adiposity and putative mediators. Diabetes Obes Metab. Published 11 March 2024. doi:10.1111/dom.15514

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.